Clinical Trial Update: Pharmacokinetic Comparisons of Two Donepezil Formulations [Phase 1]

View source ↗

Summary

A Phase 1 study comparing the pharmacokinetic profiles of two donepezil formulations in Alzheimer's disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Donepezil formulation A (Donepezil hydrochloride)
• Donepezil formulation B (Donepezil hydrochloride)

Snippet

Sponsor: Korea University Anam Hospital | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED